Newest figures come from the 10-Q for Q3 FY2026, filed Oct 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the OFSSO SEC filings page.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) reported $31.0M in revenue over the twelve months to Sep 30, 2026, down 27.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The numbers show a finance-heavy business where balance-sheet contraction and accounting volatility matter more than top-line growth.
The latest year paired a net loss of$33.1M with operating cash flow of$43.6M , revealing a cash-conversion mismatch rather than a simple cash drain. The prior year paired net income of$28.4M with operating cash flow of$33.0M , so the current gap likely reflects non-cash or timing effects.
At year-end, liabilities were 64.5% of assets and debt-to-equity was 1.3x. Equity of
Assets fell
Financial Health Signals
We do not publish a peer-relative financial health score for OFS Capital Corporation 7.50% Notes due 2028, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
OFS Capital Corporation 7.50% Notes due 2028 passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
OFS Capital Corporation 7.50% Notes due 2028 reported a net loss of $33.1M while generating $43.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
OFS Capital Corporation 7.50% Notes due 2028 generated $5.9M in revenue in Q3 2026. This represents a decrease of 43.7% from the same quarter a year earlier. Against the prior quarter it is down 13.1%.
OFS Capital Corporation 7.50% Notes due 2028 reported a net loss of $11.5M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 306.7%.
OFS Capital Corporation 7.50% Notes due 2028 earned -$0.86 per diluted share (EPS) in Q3 2026. This represents a decrease of 490.9% from the same quarter a year earlier. Against the prior quarter it is down 304.8%.
Not reported for Q3 2026.
Cash & Balance Sheet
OFS Capital Corporation 7.50% Notes due 2028 held $3.1M in cash against $127.2M in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
OFS Capital Corporation 7.50% Notes due 2028's quarterly ROE was -11.6% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 7.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 16.6 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
None of these metrics is reported for Q3 2026.
OFSSO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9M-43.7% | $6.8M-34.7% | $8.9M-13.5% | $9.4M-19.6% | $10.6M-3.4% | $10.5M-6.2% | $10.3M-27.7% | $11.6M-13.6% |
| Interest Expense | $3.2M-30.0% | $3.7M-2.8% | $3.9M+0.8% | $4.3M+8.4% | $4.5M+12.9% | $3.8M-6.7% | $3.9M-15.6% | $3.9M-15.9% |
| Net Income | -$11.5Mn/m | $5.6Mn/m | -$11.6Mn/m | -$10.8M-142.6% | -$5.3M-415.6% | -$9.6M-193.3% | -$7.3Mn/m | $25.5Mn/m |
| EPS (Basic) | -$0.86-490.9% | $0.42n/m | -$0.86n/m | -$3.19 | $0.22-18.5% | -$0.72 | -$0.54-228.6% | $0.31-11.4% |
| EPS (Diluted) | -$0.86-490.9% | $0.42n/m | -$0.86n/m | -$3.19 | $0.22-18.5% | -$0.72 | -$0.54-228.6% | $0.31-11.4% |
| Diluted Shares (Avg) | 13M0.0% | 13M0.0% | 13M0.0% | N/A | 13M0.0% | 13M | 13M0.0% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Income Tax.
OFSSO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $260.9M-31.0% | $304.5M-23.0% | $315.7M-23.4% | $346.7M-19.0% | $378.1M-9.6% | $395.4M-3.0% | $412.0M+0.4% | $428.1M-8.9% |
| Cash & Equivalents | $3.1M-37.5% | $4.0M-61.1% | $3.3M-19.6% | $3.4M-44.6% | $5.0M-75.3% | $10.2M+83.5% | $4.1M-33.5% | $6.1M-86.6% |
| Total Liabilities | $162.1M-33.0% | $191.9M-23.0% | $206.4M-18.0% | $223.5M-12.7% | $241.8M-9.5% | $249.2M-1.8% | $251.6M-4.0% | $255.9M-16.9% |
| Long-Term Debt | $127.2M-28.1% | $146.7M-18.0% | $146.4M-41.0% | $162.2M-9.0% | $176.9M-29.0% | $178.8M-28.2% | $248.1M-4.0% | $178.3M+0.6% |
| Total Equity | $98.8M-27.5% | $112.6M-23.0% | $109.3M-31.8% | $123.2M-28.5% | $136.3M-9.9% | $146.2M-5.2% | $160.4M+8.1% | $172.2M+6.3% |
| Retained Earnings | -$75.5Mn/m | -$61.7Mn/m | -$65.0Mn/m | -$51.1Mn/m | -$48.7Mn/m | -$38.9Mn/m | -$24.7Mn/m | -$12.8Mn/m |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.
OFSSO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $32.8M+444.5% | $17.4M+12.9% | $21.8M+666.3% | $19.4Mn/m | $6.0M-68.7% | $15.4M+14.5% | $2.8M-69.2% | -$8.9M-125.8% |
| Financing Cash Flow | -$33.7Mn/m | -$16.6Mn/m | -$21.9Mn/m | -$21.0Mn/m | -$11.3Mn/m | -$9.2Mn/m | -$4.9Mn/m | -$5.3Mn/m |
| Dividends Paid | $2.3M-50.0% | $0-100.0% | $2.3M-50.0% | $2.3M-50.0% | $4.6M0.0% | $4.6M0.0% | $4.6M0.0% | $4.6M0.0% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Share Buybacks.
OFSSO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Net Margin | -193.8% | 81.4%+173.3pp | -130.1% | -115.8% | -50.5%-66.0pp | -91.9%-184.4pp | -70.8%-7.2pp | 218.7% |
| Return on Equity | -11.6%-7.7pp | 4.9%+11.5pp | -10.6%-6.1pp | -8.8%-23.6pp | -3.9%-5.0pp | -6.6%-13.3pp | -4.5%+1.6pp | 14.8%+17.3pp |
| Return on Assets | -4.4%-3.0pp | 1.8%+4.3pp | -3.7%-1.9pp | -3.1%-9.1pp | -1.4%-1.8pp | -2.4%-5.0pp | -1.8%+0.4pp | 5.9%+6.8pp |
| Debt-to-Equity | 1.290.0x | 1.30+0.1x | 1.34-0.2x | 1.32+0.3x | 1.30-0.3x | 1.22-0.4x | 1.55-0.2x | 1.04-0.1x |
| Liabilities-to-Equity | 1.64-0.1x | 1.700.0x | 1.89+0.3x | 1.81+0.3x | 1.770.0x | 1.70+0.1x | 1.57-0.2x | 1.49-0.4x |
| Asset Turnover | 0.020.0x | 0.020.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x | 0.030.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Where OFS Capital Corporation 7.50% Notes due 2028 Ranks
Frequently Asked Questions
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) reported $40.7M in total revenue for fiscal year 2025. This represents a -15.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) revenue declined by 15.2% year-over-year, from $48.0M to $40.7M in fiscal year 2025.
No, OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) reported a net loss of $28.4M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $33.1M, with a net profit margin of -81.3%.
As of fiscal year 2025, OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) had $3.4M in cash and equivalents against $162.2M in long-term debt.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) had a net profit margin of -81.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) has a return on equity of -26.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) generated $43.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) had $346.7M in total assets as of fiscal year 2025, including both current and long-term assets.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) had a debt-to-equity ratio of 1.32 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) had a liabilities-to-equity ratio of 1.81 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) had a return on assets of -9.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
OFS Capital Corporation 7.50% Notes due 2028 (OFSSO) reported a net loss of $33.1M while generating $43.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.